International Journal of Cancer Management

Published by: Kowsar

Increased Nuclear Localization of β - catenin by rhBMP - 2 in the Induced Oral Squamous Cell Carcinoma in the Syrian Hamster Cheek Pouch

Khaled Waleed Zaid 1 , * , Jean Nassar 2 , Mazen Doumani 3 , Rashad Murad 4 , Charif Barakat 1 , Ali Abousulaiman 5 and Abdullah Awad 5
Authors Information
1 Department of Oral Histology and Pathology, Damascus University, Damascus, Syria
2 Department of Periodontology, Faculty of Dentistry, Lebanese University, Beirut, Lebanon
3 Department of Restorative Dental Sciences, Alfarabi College for Dentistry and Nursing, Riyadh, Saudi Arabia
4 Faculty of Pharmacy, Damascus University, Damascus, Syria
5 Department of Periodontology, Damascus, Syria
Article information
  • International Journal of Cancer Management: March 2018, 11 (3); e9850
  • Published Online: March 17, 2018
  • Article Type: Research Article
  • Received: January 22, 2017
  • Revised: April 12, 2017
  • Accepted: February 26, 2018
  • DOI: 10.5812/ijcm.9850

To Cite: Waleed Zaid K, Nassar J, Doumani M, Murad R, Barakat C, et al. Increased Nuclear Localization of β - catenin by rhBMP - 2 in the Induced Oral Squamous Cell Carcinoma in the Syrian Hamster Cheek Pouch, Int J Cancer Manag. 2018 ; 11(3):e9850. doi: 10.5812/ijcm.9850.

Copyright © 2018, Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Wagner DO, Sieber C, Bhushan R, Borgermann JH, Graf D, Knaus P. BMPs: from bone to body morphogenetic proteins. Sci Signal. 2010;3(107):mr1. doi: 10.1126/scisignal.3107mr1. [PubMed: 20124549].
  • 2. Varga AC, Wrana JL. The disparate role of BMP in stem cell biology. Oncogene. 2005;24(37):5713-21. doi: 10.1038/sj.onc.1208919. [PubMed: 16123804].
  • 3. Xiao YT, Xiang LX, Shao JZ. Bone morphogenetic protein. Biochem Biophys Res Commun. 2007;362(3):550-3. doi: 10.1016/j.bbrc.2007.08.045. [PubMed: 17719560].
  • 4. Blanco Calvo M, Bolos Fernandez V, Medina Villaamil V, Aparicio Gallego G, Diaz Prado S, Grande Pulido E. Biology of BMP signalling and cancer. Clin Transl Oncol. 2009;11(3):126-37. [PubMed: 19293049].
  • 5. Ebara S, Nakayama K. Mechanism for the action of bone morphogenetic proteins and regulation of their activity. Spine (Phila Pa 1976). 2002;27(16 Suppl 1):S10-5. [PubMed: 12205413].
  • 6. Nohe A, Keating E, Knaus P, Petersen NO. Signal transduction of bone morphogenetic protein receptors. Cell Signal. 2004;16(3):291-9. [PubMed: 14687659].
  • 7. Saldanha S, Bragdon B, Moseychuk O, Bonor J, Dhurjati P, Nohe A. Caveolae regulate Smad signaling as verified by novel imaging and system biology approaches. J Cell Physiol. 2013;228(5):1060-9. doi: 10.1002/jcp.24253. [PubMed: 23041979].
  • 8. Zaid KW, Chantiri M, Bassit G. Recombinant human bone morphogenetic Protein-2 in development and progression of oral squamous cell carcinoma. Asian Pac J Cancer Prev. 2016;17(3):927-32. [PubMed: 27039814].
  • 9. Sieber C, Kopf J, Hiepen C, Knaus P. Recent advances in BMP receptor signaling. Cytokine Growth Factor Rev. 2009;20(5-6):343-55. doi: 10.1016/j.cytogfr.2009.10.007. [PubMed: 19897402].
  • 10. Hartung A, Bitton-Worms K, Rechtman MM, Wenzel V, Boergermann JH, Hassel S, et al. Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling. Mol Cell Biol. 2006;26(20):7791-805. doi: 10.1128/MCB.00022-06. [PubMed: 16923969].
  • 11. Arce L, Yokoyama NN, Waterman ML. Diversity of LEF/TCF action in development and disease. Oncogene. 2006;25(57):7492-504. doi: 10.1038/sj.onc.1210056. [PubMed: 17143293].
  • 12. Gonzalez-Moles MA, Ruiz-Avila I, Gil-Montoya JA, Plaza-Campillo J, Scully C. beta-catenin in oral cancer: an update on current knowledge. Oral Oncol. 2014;50(9):818-24. doi: 10.1016/j.oraloncology.2014.06.005. [PubMed: 24998198].
  • 13. Bragdon B, Moseychuk O, Saldanha S, King D, Julian J, Nohe A. Bone morphogenetic proteins: a critical review. Cell Signal. 2011;23(4):609-20. doi: 10.1016/j.cellsig.2010.10.003. [PubMed: 20959140].
  • 14. Zaid KW. Immunohistochemical assessment of E-cadherin and beta-catenin in the histological differentiations of oral squamous cell carcinoma. Asian Pac J Cancer Prev. 2014;15(20):8847-53. [PubMed: 25374218].
  • 15. Ebert MP, Yu J, Hoffmann J, Rocco A, Rocken C, Kahmann S, et al. Loss of beta-catenin expression in metastatic gastric cancer. J Clin Oncol. 2003;21(9):1708-14. doi: 10.1200/JCO.2003.10.017. [PubMed: 12721245].
  • 16. Zhang Y, Liu B, Zhao Q, Hou T, Huang X. Nuclear localizaiton of beta-catenin is associated with poor survival and chemo-/radioresistance in human cervical squamous cell cancer. Int J Clin Exp Pathol. 2014;7(7):3908-17. [PubMed: 25120767].
  • 17. Lee CM, Shvartsman H, Deavers MT, Wang SC, Xia W, Schmandt R, et al. beta-catenin nuclear localization is associated with grade in ovarian serous carcinoma. Gynecol Oncol. 2003;88(3):363-8. [PubMed: 12648588].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments